1. Home
  2. EVOK vs GIPR Comparison

EVOK vs GIPR Comparison

Compare EVOK & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • GIPR
  • Stock Information
  • Founded
  • EVOK 2007
  • GIPR 2015
  • Country
  • EVOK United States
  • GIPR United States
  • Employees
  • EVOK N/A
  • GIPR N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • GIPR Real Estate Investment Trusts
  • Sector
  • EVOK Health Care
  • GIPR Real Estate
  • Exchange
  • EVOK Nasdaq
  • GIPR Nasdaq
  • Market Cap
  • EVOK 5.4M
  • GIPR 5.3M
  • IPO Year
  • EVOK 2013
  • GIPR 2021
  • Fundamental
  • Price
  • EVOK $5.12
  • GIPR $0.80
  • Analyst Decision
  • EVOK
  • GIPR
  • Analyst Count
  • EVOK 0
  • GIPR 0
  • Target Price
  • EVOK N/A
  • GIPR N/A
  • AVG Volume (30 Days)
  • EVOK 104.5K
  • GIPR 52.9K
  • Earning Date
  • EVOK 08-14-2025
  • GIPR 08-26-2025
  • Dividend Yield
  • EVOK N/A
  • GIPR N/A
  • EPS Growth
  • EVOK N/A
  • GIPR N/A
  • EPS
  • EVOK N/A
  • GIPR N/A
  • Revenue
  • EVOK $12,794,859.00
  • GIPR $9,884,093.00
  • Revenue This Year
  • EVOK $57.82
  • GIPR N/A
  • Revenue Next Year
  • EVOK $59.12
  • GIPR N/A
  • P/E Ratio
  • EVOK N/A
  • GIPR N/A
  • Revenue Growth
  • EVOK 70.02
  • GIPR 11.25
  • 52 Week Low
  • EVOK $1.94
  • GIPR $0.78
  • 52 Week High
  • EVOK $12.32
  • GIPR $2.71
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 55.77
  • GIPR 18.56
  • Support Level
  • EVOK $4.61
  • GIPR $0.80
  • Resistance Level
  • EVOK $5.70
  • GIPR $0.87
  • Average True Range (ATR)
  • EVOK 0.52
  • GIPR 0.10
  • MACD
  • EVOK -0.03
  • GIPR -0.05
  • Stochastic Oscillator
  • EVOK 71.01
  • GIPR 1.86

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: